ImmunityBio, Inc. (IBRX)
Across 12 earnings reports since Jun 11, 2021, ImmunityBio, Inc. (IBRX) has a clear post-earnings pattern. It moves ±7.10% on average after reporting and finishes higher 41.7% of the time. Its largest post-earnings gain was +14.01% (May 12, 2025) and its largest decline was -13.37% (Mar 03, 2025). The next earnings report is predicted for 2026-08-10 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
12
Avg Abs. Movement
±7.10%
Positive %
41.7%
Negative %
58.3%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 07, 2026 | ☀ PRE | $7.75 | $8.11 | $7.75 | 554,639 | -7.63% | open_in_new |
| Apr 09, 2026 | ☀ PRE | $7.00 | $7.64 | $7.48 | 21,588,100 | +7.16% | open_in_new |
| Feb 23, 2026 | ☀ PRE | $9.95 | $11.00 | $9.83 | 86,445,100 | +12.99% | open_in_new |
| Nov 05, 2025 | ☽ POST | $2.19 | $2.27 | $2.15 | 13,359,900 | -1.4% | open_in_new |
| Aug 05, 2025 | ☀ PRE | $2.40 | $2.46 | $2.41 | 6,165,700 | +0% | open_in_new |
| May 12, 2025 | ☀ PRE | $2.25 | $2.46 | $2.36 | 12,700,700 | +14.01% | open_in_new |
| Mar 03, 2025 | ☀ PRE | $3.20 | $3.25 | $2.85 | 8,632,800 | -13.37% | open_in_new |
| Nov 12, 2024 | ☀ PRE | $5.36 | $5.44 | $4.95 | 10,311,900 | -9.17% | open_in_new |
| Feb 14, 2023 | ☽ POST | $3.75 | $3.90 | $3.74 | 1,222,500 | -6.42% | open_in_new |
| Dec 12, 2022 | ☀ PRE | $5.92 | $6.82 | $6.77 | 3,225,300 | +10.08% | open_in_new |
| Sep 13, 2021 | ☀ PRE | $9.97 | $10.28 | $9.77 | 1,425,200 | -1.21% | open_in_new |
| Jun 11, 2021 | ☽ POST | $14.94 | $15.65 | $15.19 | 1,180,400 | -1.71% | open_in_new |
Earnings Count
12
Total earnings in dataset
Avg Abs. Movement
±7.10%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260610 | open_in_new SEC.gov |
| 4 | 20260610 | open_in_new SEC.gov |
| 4 | 20260610 | open_in_new SEC.gov |
| 4 | 20260610 | open_in_new SEC.gov |
| 4 | 20260610 | open_in_new SEC.gov |
| 4 | 20260610 | open_in_new SEC.gov |
| 8-K | 20260610 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 144 | 20260604 | open_in_new SEC.gov |
| 8-K | 20260518 | open_in_new SEC.gov |
Frequently asked about IBRX earnings
When does ImmunityBio, Inc. report earnings next? expand_more
ImmunityBio, Inc. (IBRX)'s next earnings date is approximate for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does IBRX stock move after earnings? expand_more
Over 12 reports, IBRX has moved an average of ±7.10% the session after earnings, closing higher 41.7% of the time.
What was IBRX's biggest post-earnings move? expand_more
IBRX's largest post-earnings gain on record was +14.01% on May 12, 2025, and its largest decline was -13.37% on Mar 03, 2025.
Where can I find ImmunityBio, Inc.'s SEC filings? expand_more
All of ImmunityBio, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right